Literature DB >> 27432409

Hepatitis B and C in the Syrian Arab Republic: a review.

H Bashour1, G Muhjazi2.   

Abstract

This paper reviews the epidemiology and determinants of hepatitis B and C in the Syrian Arab Republic as well as their treatment and prevention. A systematic search of Medline, PubMed and Index Medicus for the Eastern Mediterranean Region was carried out in addition to a review of grey literature and relevant datasets in the Syrian Arab Republic. Low to low-intermediate levels of endemicity of both infections were noted at the national level. However, striking geographic differences and high prevalence among high-risk groups were noticeable. As a result of data limitations, further research is needed, and a national control strategy to combat hepatitis B and C in the Syrian Arab Republic should be developed, especially during the current conflict.

Entities:  

Mesh:

Year:  2016        PMID: 27432409     DOI: 10.26719/2016.22.4.267

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  4 in total

Review 1.  Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees.

Authors:  Ö Ergönül; N Tülek; I Kayı; H Irmak; O Erdem; M Dara
Journal:  Clin Microbiol Infect       Date:  2019-07-05       Impact factor: 8.067

Review 2.  Hepatitis C virus infection in children in the era of direct-acting antiviral.

Authors:  Malgorzata Pawlowska; Malgorzata Sobolewska-Pilarczyk; Krzysztof Domagalski
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

3.  Systematic overview of hepatitis C infection in the Middle East and North Africa.

Authors:  Karima Chaabna; Sohaila Cheema; Amit Abraham; Hekmat Alrouh; Albert B Lowenfels; Patrick Maisonneuve; Ravinder Mamtani
Journal:  World J Gastroenterol       Date:  2018-07-21       Impact factor: 5.742

4.  Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016.

Authors:  A von Laer; M Diercke; M An der Heiden; D Altmann; R Zimmermann; S Dudareva
Journal:  Epidemiol Infect       Date:  2020-02-24       Impact factor: 2.451

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.